Clinical Trials Browser

Phase 2 × Interventional × Botulinum Toxins, Type A × Clear all

NCT06807164 2026-03-17

SerCaBot

Phase 2 Recruiting

Agnosia, Breast Neoplasms

NCT04965311 2025-05-13

Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy

Phase 2 Terminated

4 enrolled 9 charts

Gastrointestinal

Pancreatic Neoplasms

NCT06530524 2024-07-31

Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery

Phase 2 Not yet recruiting

Head and Neck Neoplasms

NCT02965976 2023-02-16

Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer

Phase 2 Completed

33 enrolled 17 charts

Gastrointestinal

Esophageal Neoplasms

NCT01822210 2018-03-09

Botulinum Toxin for Stomach Cancer Treatment

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms

NCT01589471 2018-02-12

The Value of Botox-A for Management of Low Anterior Resection Syndrome

Phase 2 Completed

Gastrointestinal

Low Anterior Resection Syndrome, Rectal Neoplasms

NCT00681148 2013-11-21

Botulinum Toxin Injection With Prostate Brachytherapy

Phase 2 Withdrawn

Prostatic Neoplasms, Lower Urinary Tract Symptoms